Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nexalin Technology Inc (NXL)

Nexalin Technology Inc (NXL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 33,827
  • Shares Outstanding, K 12,862
  • Annual Sales, $ 110 K
  • Annual Income, $ -4,650 K
  • EBIT $ -7 M
  • EBITDA $ -7 M
  • 60-Month Beta 3.78
  • Price/Sales 354.57
  • Price/Cash Flow N/A
  • Price/Book 6.53

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.55 +3.30%
on 12/20/24
4.49 -41.42%
on 12/04/24
-1.17 (-30.79%)
since 11/20/24
3-Month
0.59 +345.01%
on 10/10/24
4.49 -41.42%
on 12/04/24
+1.94 (+278.85%)
since 09/20/24
52-Week
0.25 +940.35%
on 02/13/24
4.49 -41.42%
on 12/04/24
+2.34 (+806.90%)
since 12/20/23

Most Recent Stories

More News
Nexalin Technology, Inc. Announces Validation of DIFS Technology in Peer-Reviewed Editorial on Psychiatric Treatment

Nexalin's DIFS technology gains validation in Psychotherapy and Psychosomatics, highlighting its potential for treating psychiatric disorders non-invasively.Quiver AI SummaryNexalin Technology, Inc. has...

NXL : 2.63 (-14.05%)
New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market

NXL : 2.63 (-14.05%)
NXLIW : 0.3799 (+22.55%)
Nexalin Technology CEO Provides Letter to Shareholders

NXL : 2.63 (-14.05%)
NXLIW : 0.3799 (+22.55%)
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th

NXL : 2.63 (-14.05%)
NXLIW : 0.3799 (+22.55%)
Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements

NXL : 2.63 (-14.05%)
NXLIW : 0.3799 (+22.55%)
Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's Disease

NXL : 2.63 (-14.05%)
NXLIW : 0.3799 (+22.55%)
Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA

NXL : 2.63 (-14.05%)
NXLIW : 0.3799 (+22.55%)
New Study Shows Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer’s Patients

NXL : 2.63 (-14.05%)
NXLIW : 0.3799 (+22.55%)
Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory Affairs

NXL : 2.63 (-14.05%)
NXLIW : 0.3799 (+22.55%)

Business Summary

Nexalin Technology Inc. designs and develops neurostimulation products for mental health epidemic. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. Nexalin Technology Inc. is based in Houston, Texas.

See More

Key Turning Points

3rd Resistance Point 3.46
2nd Resistance Point 3.26
1st Resistance Point 2.94
Last Price 2.63
1st Support Level 2.43
2nd Support Level 2.23
3rd Support Level 1.92

See More

52-Week High 4.49
Fibonacci 61.8% 2.87
Last Price 2.63
Fibonacci 50% 2.37
Fibonacci 38.2% 1.87
52-Week Low 0.25

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar